Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey (1988-1994)

Archives of Internal Medicine

Volumn 162, Issue 12, 2002, Pages 1401-1408

  Astor, Brad C ^a,b   Muntner, Paul ^c   Levin, Adeera ^d,f,g,h,i   Eustace, Joseph A ^e   Coresh, Josef ^a,b,e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c TULANE UNIVERSITY   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Amqen Inc

^g OrthoBiotech Inc   (United States)

^h JANSSEN CILAG GMBH   (Germany)

ⁱ F Hoffmann La Roche in North America   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANEMIA; ARTICLE; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RACE; UNITED STATES;

EID: 0037166636     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.12.1401     Document Type: Article

References (45)

1. Excerpts from the US Renal Data System 1999 Annual Data Report
2. Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the Third National Health and Nutrition Examination Survey (1988-1994)
3. Anemia of end-stage renal disease (ESRD)
4. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis
5. Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin
6. Long-term evolution of cardiomyopathy in dialysis patients
7. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors
8. The USRDS Dialysis Morbidity and Mortality Study: Wave 2: United States Renal Data System
9. Clinical epidemiology of cardiovascular disease in chronic renal disease
10. IV: NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000
11. Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States
12. Serum erythropoietin concentration in chronic renal failure: Relationship to degree of anemia and excretory renal function
13. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency
14. Analysis of the quantitative relationship between anemia and chronic renal failure
15. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease
16. Relationship between hematocrit and renal function in men and women
17. An estimate of the size of the US pre-dialysis population with renal insufficiency and anemia
18. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94: Series 1: Programs and collection procedures
19. Sample design: Third National Health and Nutrition Examination Survey
20. Laboratory assessment of renal disease: Clearance, urinalysis, and renal biopsy
21. A simplified equation to predict glomerular filtration rate from serum creatinine
22. Practical considerations in the analysis of complex sample survey data
23. qreg: Quantile (including median) regression
24. The minimum sum of absolute errors regression: A state of the art survey
25. mkspline: Linear spline construction
26. The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
27. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
28. Defining a renal anemia management period
29. Effects of anaemia on cardiovascular status
30. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
31. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin
32. Effect of recombinant erythropoietin on hospital admissions, readmissions, length of stay, and costs of dialysis patients
33. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
34. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
35. Cardiovascular effects of recombinant human erythropoietin in predialysis patients
36. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure
37. Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center
38. Greater incidence of electrocardiographic left ventricular hypertrophy in black men than in white men in Evans County, Georgia
39. Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state
40. Intravenous iron for the treatment of predialysis anemia
41. Anemia management in patients with chronic renal insufficiency
42. Serum creatinine and renal function
43. Serum creatinine as an index of renal function: New insights into old concepts